The following news release is from einnews.com.
Today 23andMe, an industry leader in personal genetics, announced the appointment of Ashley Ledbetter Dombkowski, PhD as Chief Business Officer. Dr. Dombkowski will assume global responsibility for 23andMe’s translational collaboration initiatives and will join the company’s executive leadership team reporting directly to 23andMe CEO and Co-Founder Anne Wojcicki. Dr. Dombkowski had previously been a member of 23andMe’s Board of Directors.
“Ashley’s remarkable ability to bring strategic vision to cutting edge technologies has resulted in increased levels of innovation, productivity and success for health care companies,” said Wojcicki. “We are confident her extensive experience working with physicians, academic researchers, patient-advocacy groups and entrepreneurs will complement the world-class expertise 23andMe has assembled in genetics, medicine, information technology, ancestry, privacy and consumer-focused fields. Ashley shares 23andMe’s goal of empowering individuals with their own genetic information and working to facilitate and accelerate research on their behalf. I’m delighted to welcome her to the company in this new, fully-dedicated role.”
“23andMe has pioneered a compelling approach to genetics by allowing individuals to learn from and interact with their own DNA while also contributing to research that could improve their lives,” said Dombkowski. “As a result of the company’s web-based research and rapidly growing database, the platform has already demonstrated unprecedented research utility. My aim is to ensure that discoveries made by, and on behalf of, our community can be translated so that users are not only participating in research, but benefiting from it.”
Dombkowski joins 23andMe after eleven years at MPM Capital where she served as Managing Director and a member of the firm’s Investment Committee. Prior to MPM she was a Health Care Analyst at Tiger Management and Dresdner RCM Global Investors. Dr. Dombkowski holds a Ph.D. in Mathematics from Rice University and a B.A. in Mathematics from Wellesley College.
About 23andMe
23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company’s Personal Genome Service® enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. More information is available at www.23andme.com.
